Evaluation of a Telemedicine System for the Transmission of Morpho/Immunological Data Aiming at the Inclusion of Patients in a Therapeutic Trial
Due to their high levels of achievement and efficiency, image digitalization and teletransmission tools are more and more frequently used. Applied to cellular haematology, these tools often contribute to diagnosis confrontation, sometimes within the framework of therapeutic trials. We present one of...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2009-01-01
|
| Series: | International Journal of Telemedicine and Applications |
| Online Access: | http://dx.doi.org/10.1155/2009/767145 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832561002368991232 |
|---|---|
| author | Jean-François Lesesve Richard Garand |
| author_facet | Jean-François Lesesve Richard Garand |
| author_sort | Jean-François Lesesve |
| collection | DOAJ |
| description | Due to their high levels of achievement and efficiency, image digitalization and teletransmission tools are more and more frequently used. Applied to cellular haematology, these tools often contribute to diagnosis confrontation, sometimes within the framework of therapeutic trials. We present one of the first approaches of the use of telehaematology for the inclusion of patients in the GOELAMS chronic lymphocytic leukaemia 98 trial. The advantages were (1) the creation of a unique, protected, stable data bank that could be remotely consulted, (2) the use of digitized pictures which made expertise on identical documents possible, (3) the facility of computer exchanges between experts, in terms of reception as well as replying time delays. We were able to set out new standards of image sampling for CLL, solve the semantic divergences, and point out interobserver variability as regards morphology. The limiting factors were the important need for expert investment, but they more importantly concerned the first line morphologists who should benefit from adequate tools, in terms of computer equipment as well as members of staff, so as to apprehend this second reading system as a quality control procedure. |
| format | Article |
| id | doaj-art-1f215544369e47aab422c2835919c8db |
| institution | Kabale University |
| issn | 1687-6415 1687-6423 |
| language | English |
| publishDate | 2009-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | International Journal of Telemedicine and Applications |
| spelling | doaj-art-1f215544369e47aab422c2835919c8db2025-02-03T01:26:13ZengWileyInternational Journal of Telemedicine and Applications1687-64151687-64232009-01-01200910.1155/2009/767145767145Evaluation of a Telemedicine System for the Transmission of Morpho/Immunological Data Aiming at the Inclusion of Patients in a Therapeutic TrialJean-François Lesesve0Richard Garand1Centre Hospitalier Universitaire de Nancy et de Nantes (CHU Nancy et Nantes), 54000 Nancy, FranceCentre Hospitalier Universitaire de Nancy et de Nantes (CHU Nancy et Nantes), 54000 Nancy, FranceDue to their high levels of achievement and efficiency, image digitalization and teletransmission tools are more and more frequently used. Applied to cellular haematology, these tools often contribute to diagnosis confrontation, sometimes within the framework of therapeutic trials. We present one of the first approaches of the use of telehaematology for the inclusion of patients in the GOELAMS chronic lymphocytic leukaemia 98 trial. The advantages were (1) the creation of a unique, protected, stable data bank that could be remotely consulted, (2) the use of digitized pictures which made expertise on identical documents possible, (3) the facility of computer exchanges between experts, in terms of reception as well as replying time delays. We were able to set out new standards of image sampling for CLL, solve the semantic divergences, and point out interobserver variability as regards morphology. The limiting factors were the important need for expert investment, but they more importantly concerned the first line morphologists who should benefit from adequate tools, in terms of computer equipment as well as members of staff, so as to apprehend this second reading system as a quality control procedure.http://dx.doi.org/10.1155/2009/767145 |
| spellingShingle | Jean-François Lesesve Richard Garand Evaluation of a Telemedicine System for the Transmission of Morpho/Immunological Data Aiming at the Inclusion of Patients in a Therapeutic Trial International Journal of Telemedicine and Applications |
| title | Evaluation of a Telemedicine System for the Transmission of Morpho/Immunological Data Aiming at the Inclusion of Patients in a Therapeutic Trial |
| title_full | Evaluation of a Telemedicine System for the Transmission of Morpho/Immunological Data Aiming at the Inclusion of Patients in a Therapeutic Trial |
| title_fullStr | Evaluation of a Telemedicine System for the Transmission of Morpho/Immunological Data Aiming at the Inclusion of Patients in a Therapeutic Trial |
| title_full_unstemmed | Evaluation of a Telemedicine System for the Transmission of Morpho/Immunological Data Aiming at the Inclusion of Patients in a Therapeutic Trial |
| title_short | Evaluation of a Telemedicine System for the Transmission of Morpho/Immunological Data Aiming at the Inclusion of Patients in a Therapeutic Trial |
| title_sort | evaluation of a telemedicine system for the transmission of morpho immunological data aiming at the inclusion of patients in a therapeutic trial |
| url | http://dx.doi.org/10.1155/2009/767145 |
| work_keys_str_mv | AT jeanfrancoislesesve evaluationofatelemedicinesystemforthetransmissionofmorphoimmunologicaldataaimingattheinclusionofpatientsinatherapeutictrial AT richardgarand evaluationofatelemedicinesystemforthetransmissionofmorphoimmunologicaldataaimingattheinclusionofpatientsinatherapeutictrial |